Diagnostics
PATH advances and increases access to quality and appropriate diagnostics that improve the health outcomes of people and communities in low-resource settings.
Contact
What we do
Diagnostics are essential for advancing universal health coverage, addressing health emergencies, and promoting healthier populations. These critical tools guide clinical decision-making for patient care, curb the spread of drug resistance, support disease surveillance programs, and raise early alerts of a potential pandemic disease.
However, more than 50 percent of the world’s population has little to no access to basic diagnostics. Current diagnostics are either completely unavailable where most patients live and present for treatment or are too expensive or resource-intensive for local health systems to acquire and use.
For more than 30 years, PATH Diagnostics has collaborated with partners across the full diagnostics ecosystem to develop and commercialize appropriate, affordable, quality-assured diagnostics for conditions that disproportionately affect people in low-resource settings.
PATH’s global footprint and country capabilities accelerate improvements in delivery and access to health products.
We ensure that developers have the tools to advance appropriate, quality-assured diagnostics that meet pressing public health needs. We do this by creating an enabling ecosystem for R&D and product adoption. This includes creating specimen panels and antibodies, product testing, conducting post-market surveillance, and supporting the introduction of new diagnostic tools and approaches with quality assurance programs and methods.
Through operational, user, and lab-based research, we facilitate the generation of actionable evidence at each step of the diagnostics development life cycle to ensure that solutions are context-appropriate, user-driven, and perform as required. Rigorous evaluation of prototypes before advancing their development ensures that useful, high-quality products enter the market.
We collaborate with ministries of health, technology companies, manufacturers, and implementation partners to develop and scale fit-for-purpose digital diagnostic solutions that inform decision-making, patient care, usability, and surveillance and reporting within the broader digital health ecosystem.
We combine market access capabilities with broad technical expertise in developing and scaling innovative diagnostics solutions to ensure product viability, sustainability, and sound investment decisions. We help to identify alternative mechanisms to increase and strengthen the supply of diagnostics in low-resource setting markets through market interventions and support for local manufacturing and distribution.
Partnering with ministries of health and national regulatory authorities, we help stakeholders to understand and determine diagnostic needs and financing mechanisms required to support informed decision-making.
Our focus areas
Diagnostics Leadership
-
![]()
Neha Agarwal
Co-Lead, Diagnostics
-
![]()
David Boyle
Laboratory Director and Program Co-Lead, Diagnostics
-
![]()
Jennifer Chin
Director of Finance & Operations, Diagnostics
-
![]()
Gonzalo Domingo
Scientific Director and Lead of Malaria Diagnostics
-
![]()
Bhavya Gowda
Lead, Market Access and Commercialization
-
![]()
Deborah Oroszlan
Digital Engagement & Communications
-
![]()
Roger Peck
Associate Director, Diagnostics
-
![]()
Helen Storey
Program Advisor, Diagnostics
